Division of Gastrointestinal and Liver Disease, Keck School of Medicine, University of Southern California, Los Angeles, California 90033, USA.
Gastroenterology. 2010 May;138(5):1673-1680.e1; quiz e11-2. doi: 10.1053/j.gastro.2010.01.047. Epub 2010 Feb 2.
BACKGROUND & AIMS: Capsule endoscopy improves the diagnostic yield in patients with obscure gastrointestinal (GI) bleeding, but whether it improves outcomes is uncertain.
Patients with obscure GI bleeding and negative upper endoscopy, colonoscopy, and push enteroscopy were randomly assigned to capsule endoscopy or dedicated small bowel contrast radiography. Patients returned at 1, 2, 3, 6, 9, and 12 months for follow-up visits and to check hemoglobin level. The primary endpoint was further bleeding.
The predefined sample size of 136 patients (54 overt bleeding, 82 occult bleeding) was enrolled. Diagnostic yield was 20 (30%) with capsule vs 5 (7%) with radiography (difference = 23%; 95% CI: 11%-36%). Further bleeding with capsule versus radiography occurred in 20 (30%) versus 17 (24%) (difference, 6%; 95% confidence interval [CI], -9% to 21%), subsequent diagnostic or therapeutic interventions for bleeding were performed in 17 (26%) versus 15 (21%) (difference, 4%; 95% CI, -10% to 19%), subsequent hospitalizations for bleeding were required in 8 (12%) versus 4 (6%) (difference, 6%; 95% CI, -3% to 16%), and subsequent blood transfusions were given in 5 (8%) versus 4 (6%) (difference, 2%; 95% CI, -7% to 10%). Further bleeding was more common in patients presenting with overt bleeding than in those with occult bleeding (21/54 [39%] vs 16/82 [20%]; difference, 19%; 95% CI, 4% to 35%).
The significant improvement in diagnostic yield with capsule endoscopy may not translate into improved outcomes in a population with obscure GI bleeding. Most patients do well whether or not abnormalities are identified, and additional diagnostic or therapeutic interventions may be required whether or not capsule endoscopy identifies a source of bleeding.
胶囊内镜可提高不明原因胃肠道(GI)出血患者的诊断率,但对改善结局的作用尚不确定。
经上消化道内镜、结肠镜和推进式小肠镜检查均为阴性的不明原因 GI 出血患者被随机分配至胶囊内镜组或专用小肠造影组。患者于 1、2、3、6、9 和 12 个月时进行随访和血红蛋白水平检查。主要终点是再次出血。
本研究纳入了预设样本量为 136 例患者(显性出血 54 例,隐匿性出血 82 例)。胶囊内镜组的诊断率为 20(30%),而造影组为 5(7%)(差值=23%;95%CI:11%-36%)。胶囊内镜组和造影组再次出血的发生率分别为 20(30%)和 17(24%)(差值,6%;95%置信区间[CI]:-9%至 21%),随后因出血进行诊断或治疗干预的比例分别为 17(26%)和 15(21%)(差值,4%;95%CI:-10%至 19%),随后因出血住院的比例分别为 8(12%)和 4(6%)(差值,6%;95%CI:-3%至 16%),随后输血的比例分别为 5(8%)和 4(6%)(差值,2%;95%CI:-7%至 10%)。显性出血患者较隐匿性出血患者再次出血更常见(54 例患者中 21 例[39%] vs 82 例患者中 16 例[20%];差值,19%;95%CI:4%至 35%)。
胶囊内镜在提高不明原因胃肠道出血患者的诊断率方面有显著改善,但这可能不会转化为结局的改善。大多数患者无论是否发现异常情况均预后良好,且无论胶囊内镜是否发现出血来源,都可能需要进行额外的诊断或治疗干预。